Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 87

1.

RETRACTED ARTICLE: Regulation of estrogen receptor signaling in breast carcinogenesis and breast cancer therapy.

[No authors listed]

Cell Mol Life Sci. 2014 Apr;71(8):1549. doi: 10.1007/s00018-013-1376-3. Epub 2013 Jun 5. No abstract available.

2.

Estrogen receptor potentiates mTORC2 signaling in breast cancer cells by upregulating superoxide anions.

Kumari Kanchan R, Tripathi C, Singh Baghel K, Kumar Dwivedi S, Kumar B, Sanyal S, Sharma S, Mitra K, Garg V, Singh K, Sultana S, Kamal Tripathi R, Kumar Rath S, Bhadauria S.

Free Radic Biol Med. 2012 Nov 15;53(10):1929-41. doi: 10.1016/j.freeradbiomed.2012.08.595. Epub 2012 Sep 7.

PMID:
23000059
3.

Novel insight into KLF4 proteolytic regulation in estrogen receptor signaling and breast carcinogenesis.

Hu D, Zhou Z, Davidson NE, Huang Y, Wan Y.

J Biol Chem. 2012 Apr 20;287(17):13584-97. doi: 10.1074/jbc.M112.343566. Epub 2012 Mar 2.

4.

Functional analysis of familial Asp67Glu and Thr1051Ser BRCA1 mutations in breast/ovarian carcinogenesis.

Pongsavee M, Patmasiriwat P, Saunders GF.

Int J Mol Sci. 2009 Sep 24;10(9):4187-97. doi: 10.3390/ijms10094187.

5.

Four-and-a-half-LIM protein 1 down-regulates estrogen receptor α activity through repression of AKT phosphorylation in human breast cancer cell.

Zhang F, Feng F, Yang P, Li Z, You J, Xie W, Gao X, Yang J.

Int J Biochem Cell Biol. 2012 Feb;44(2):320-6. doi: 10.1016/j.biocel.2011.11.002. Epub 2011 Nov 10.

PMID:
22094188
6.

Expression of estrogen receptor beta wt isoform (ERbeta1) and ERbetaDelta5 splice variant mRNAs in sporadic breast cancer.

Mandusić V, Nikolić-Vukosavljević D, Tanić N, Kanjer K, Neskovic-Konstantinović Z, Celeketić D, Dimitrijević B.

J Cancer Res Clin Oncol. 2007 Aug;133(8):571-9. Epub 2007 Apr 25.

PMID:
17457609
7.

AKT3 regulates ErbB2, ErbB3 and estrogen receptor α expression and contributes to endocrine therapy resistance of ErbB2(+) breast tumor cells from Balb-neuT mice.

Grabinski N, Möllmann K, Milde-Langosch K, Müller V, Schumacher U, Brandt B, Pantel K, Jücker M.

Cell Signal. 2014 May;26(5):1021-9. doi: 10.1016/j.cellsig.2014.01.018. Epub 2014 Jan 24.

PMID:
24463007
8.

New approaches to reverse resistance to hormonal therapy in human breast cancer.

Weinberg OK, Marquez-Garban DC, Pietras RJ.

Drug Resist Updat. 2005 Aug;8(4):219-33. Epub 2005 Jul 27. Review.

PMID:
16054421
9.
11.

Decursin and decursinol angelate inhibit estrogen-stimulated and estrogen-independent growth and survival of breast cancer cells.

Jiang C, Guo J, Wang Z, Xiao B, Lee HJ, Lee EO, Kim SH, Lu J.

Breast Cancer Res. 2007;9(6):R77.

12.

Androgen receptor as a targeted therapy for breast cancer.

Garay JP, Park BH.

Am J Cancer Res. 2012;2(4):434-45. Epub 2012 Jun 28.

13.

ER-α36-mediated rapid estrogen signaling positively regulates ER-positive breast cancer stem/progenitor cells.

Deng H, Zhang XT, Wang ML, Zheng HY, Liu LJ, Wang ZY.

PLoS One. 2014 Feb 18;9(2):e88034. doi: 10.1371/journal.pone.0088034. eCollection 2014.

14.

Estrogen and growth factor signaling pathway: basic approaches for clinical application.

Hayashi S, Sakamoto T, Inoue A, Yoshida N, Omoto Y, Yamaguchi Y.

J Steroid Biochem Mol Biol. 2003 Sep;86(3-5):433-42.

PMID:
14623541
15.
16.

Estrogen-induced reactive oxygen species-mediated signalings contribute to breast cancer.

Okoh V, Deoraj A, Roy D.

Biochim Biophys Acta. 2011 Jan;1815(1):115-33. doi: 10.1016/j.bbcan.2010.10.005. Epub 2010 Oct 29. Review.

PMID:
21036202
17.

The 38th David A. Karnofsky lecture: the paradoxical actions of estrogen in breast cancer--survival or death?

Jordan VC.

J Clin Oncol. 2008 Jun 20;26(18):3073-82. doi: 10.1200/JCO.2008.17.5190. Epub 2008 Jun 2.

18.

MicroRNA-191, an estrogen-responsive microRNA, functions as an oncogenic regulator in human breast cancer.

Nagpal N, Ahmad HM, Molparia B, Kulshreshtha R.

Carcinogenesis. 2013 Aug;34(8):1889-99. doi: 10.1093/carcin/bgt107. Epub 2013 Mar 29.

20.

Mechanisms of endocrine resistance and novel therapeutic strategies in breast cancer.

Normanno N, Di Maio M, De Maio E, De Luca A, de Matteis A, Giordano A, Perrone F; NCI-Naple Breast Cancer Group.

Endocr Relat Cancer. 2005 Dec;12(4):721-47. Review.

Items per page

Supplemental Content

Write to the Help Desk